Abstract:Objectives: To comprehensively investigate nasopharyngeal carcinoma (NPC) treatment, overall survival (OS), and the influence of clinical/sociodemographic factors on outcome. Study design: Retrospective database study. Setting: National Cancer Database. Methods: The 2004-2015 National Cancer Database was queried for all patients with NPC receiving definitive treatment. Log-rank tests and Cox proportional hazards models were used for statistical analyses. Results: A total of 8260 patients with NPC were included (71.4% male; 42.5% with keratinizing histology; mean ± SD age, 52.1 ± 15.1 years), with a 5-year OS of 63.4%. Multivariate predictors of mortality included age ≥65 years (hazard ratio [HR], 1.81; P < .001), Charlson/Deyo score ≥1 (HR, 1.27; P = .001), American Joint Committee on Cancer clinical stage III to IV (HR, 1.85; P < .001), and government insurance or no insurance (HR, 1.53; P < .001). Predictors of survival included female sex (HR, 0.82; P = .002), Asian/Pacific Islander race (HR, 0.74; P < .001), nonkeratinizing/undifferentiated histology (HR, 0.79; P = .004), and receiving treatment at academic centers (HR, 0.87; P = .02). Chemoradiotherapy (CRT) demonstrated improved OS as compared with radiotherapy (RT) only for stage II (P = .006) and stage III (P = .005) and with RT or chemotherapy only in stage IVA NPC (P < .001). When compared with CRT alone, surgery plus CRT provided OS benefits in keratinizing (P = .013) or stage IVA (P = .030) NPC. When compared with RT, CRT provided OS benefits in keratinizing (P = .005) but not nonkeratinizing (P = .240) or undifferentiated (P = .390) NPC. Substandard radiation dosing of <60 Gy and <30 fractions were associated with inferior OS (both P < .001). Conclusions: NPC survival is dependent on a variety of clinical/sociodemographic factors. Stage-specific treatments with optimal OS include CRT or RT for stages I to II and CRT for stage III to IV. The large representation of nonendemic histology is valuable, as these cases are not well characterized.

Progress in the comprehensive treatment of nasopharyngeal carcinoma: a review for risk-stratified management strategies

Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA.

Surgical treatment of nasopharyngeal cancer - a consensus recommendation from two Chinese associations

Recent advances in early detection of nasopharyngeal carcinoma

Chinese Expert Consensus on Diagnosis and Treatment of Nasopharyngeal Carcinoma: Evidence from Current Practice and Future Perspectives

Nasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment Options

Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma

Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect

Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders

Nasopharyngeal carcinoma: an evolving paradigm

Comprehensive Treatment of Recurrent and Metastatic Nasopharyngeal Carcinoma: Advances and Future Directions

Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era

A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma

Role of combined surgical and radiotherapy treatment in nonmetastatic WHO I nasopharyngeal carcinoma patients

Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?

Progress in the clinical development of investigational systemic agents for recurrent and metastatic nasopharyngeal carcinoma

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)

Advances on clinical stage of nasopharyngeal carcinoma

A systematic review of the predictive value of radiomics for nasopharyngeal carcinoma prognosis